Ballicules.com

Chlorpromazine injection

THORAZINE IM

What it isIntramuscular D2 and 5-HT2A antagonist with strong H1, alpha-1, and muscarinic blockade; agitation, psychosis, emesis, and hiccups.

Why this oneIts parenteral intractable-hiccup indication is unusual among antipsychotics.

What limits itOrthostatic hypotension can be profound — keep the patient supine; local tissue irritation, antimuscarinic toxicity, and QT prolongation also matter.

FDA-approved for

FDA label

BOXED WARNING Increased mortality in elderly patients with dementia-related psychosis; not approved for dementia-related psychosis.
FDA dosingPopulationStartTargetMax
Acute schizophrenia/manic states (hospitalized)Adults25 mg IMAdd 25–50 mg IM in 1 h if needed; increase over daysUp to 400 mg every 4–6 h in exceptionally severe cases
Nausea and vomitingAdults25 mg IM25–50 mg IM every 3–4 h PRN until vomiting stops
Presurgical apprehensionAdults12.5–25 mg IM 1–2 h before surgery
Intractable hiccups / acute intermittent porphyria / tetanus (adjunct)Adults25–50 mg IM (hiccups/tetanus); 25 mg IM TID–QID (porphyria)
Severe behavioral problems / nausea and vomitingChildren 6 months–12 yr0.25 mg/lb IM every 6–8 h PRN≤5 yr (≤50 lb): 40 mg/day; 5–12 yr (50–100 lb): 75 mg/day

Renal Use with caution in renal disease.

Hepatic Use with caution in hepatic disease; increased CNS sensitivity in cirrhosis/hepatic encephalopathy.

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Undefined.

Lactation Undefined.

⚠ BOXED WARNING

Classes and tags

Clinical profile

Direct muscarinic antagonism3 / 4

Mechanism of action: Chlorpromazine injection ballicule

Chlorpromazine injection ballicule: receptor binding, kinetics and half-life diagram

Open Chlorpromazine injection in the interactive console ↗